Citizen Petition from The Doctor Patient Forum
Details
The document's own metadata, straight from the source system.
- Title
- Citizen Petition from The Doctor Patient Forum
- Posted
- Mar 12, 2025
- Comment period
- Mar 12, 2025 – ?
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type.
Comments over time
Weekly arrivals, stacked by stance.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Position map
Who stands where on each issue?
Every non-silent position is backed by an excerpt from the comment.
Issues shown
Choose up to five.
| Organization | Ai in medical practice | Algorithmic bias in healthcare | Narxcare regulation |
|---|
1 organization-typed comment could not be identified.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- Jul 11, 2026Comment from lisa JohnsonSupportIndividualRead comment →
- May 25, 2026Comment from Deborah MayoSupportIndividual
The commenter supports the proposed action to stop Narxcare and reduce DEA involvement in patient treatment. They argue that the current system unfairly penalizes elderly patients with real medical issues and advocate for more compassion in medical care.
Read comment → - May 23, 2026Comment from Jeanette FrenchSupportIndividual
The commenter is requesting that the FDA classify NarxCare as Software as a Medical Device (SaMD) to ensure it is regulated and transparent. They argue that the current lack of oversight affects real medical care and that patients and doctors lack visibility into how the scores are generated.
Read comment → - May 23, 2026Comment from AnonymousSupportIndividualRead comment →
- May 23, 2026Comment from Jim BrindleSupportIndividual
An individual with chronic pain and neuropathy supports the petition to have NarxCare regulated by the FDA or another government agency. The commenter expresses frustration over being denied pain medication and a lack of transparency regarding their NarxCare score.
Read comment → - Apr 18, 2026Comment from Michelle MylottOpposeIndividual
A patient advocate expresses concern that an unregulated database could be used to arbitrarily deny medical care to vulnerable individuals. They argue that any database with the power to make life-changing decisions must be subject to regulation and that independent companies should not hold such authority.
Read comment → - Mar 27, 2026Comment from AnonymousSupportIndividual
The commenter argues that healthcare providers are withholding information from patients and that government surveillance of patient records must end. They advocate for intense governmental supervision of Narxcare and Bamboo to protect patient rights and ensure accuracy in medical records.
Read comment → - Mar 26, 2026Comment from Megan WainwrightSupportIndividual
The commenter, a patient with complex health conditions, advocates for the regulation of NarxCare as Software as a Medical Device (SaMD) by the FDA. They argue that such regulation is necessary to ensure safety, transparency, and accountability for tools that directly impact patient care and to prevent medical errors.
Read comment → - Feb 12, 2026Comment from Michelle PrescottSupportIndividualRead comment →
- Feb 12, 2026Comment from Brian JonesOpposeIndividual
The commenter, a disabled individual, argues that the NarxCare system unfairly influences medical decisions by creating a "Draconian" environment for pain management. They contend that the risk scores provide lawyers with ammunition for lawsuits, effectively scaring doctors away from prescribing necessary opioids for post-operative pain.
Read comment →
